HealthLeaders Media February 22, 2024
A bipartisan coalition of 39 AGs wants Congress and the FTC ‘to ensure fulsome regulation of PBMs nationwide.’
KEY TAKEAWAYS
– The AGs claim that a ‘small number of PBMs hold significant market power and are reaping abundant profits at the expense of the patients, employers, and government payors the PBMs are supposed to help.’
– The AGs are urgin Congress to pass three bills that would address alleged PBM abuses at the federal level and back states’ efforts to regulate the drug purchas middlemen.
– PBMs say they’re being unfairly scapegoated for high drug costs that are set by drugmakers using anti-competitive tactics such as extending drug patent monopolies.
The National Association of Attorneys General is urging Congress...
Today's Sponsors
Today's Sponsor